Evidence map›Paper›PMID 42512301›Full record

ReviewCancers2026

Applications of Artificial Intelligence in the Endoscopic Detection and Characterization of Early Esophageal Squamous Cell Carcinoma: A Scoping Review.

Faure Rodríguez-Velásquez, Andrés Montoya-Durán, Nicole Bonilla, Jacobo Echeverri-Hoyos, Jaime A Echeverri-Franco, Eduardo Tuta-Quintero

Abstract readReview
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Faure Rodríguez-VelásquezDepartment of Gastroenterology, School of Medicine, Universidad de La Sabana, Chía 250001, Colombia.ORCID 0000-0002-1807-0221
Andrés Montoya-DuránDepartment of Gastroenterology, School of Medicine, Universidad de La Sabana, Chía 250001, Colombia.
Nicole BonillaSchool of Medicine, Universidad de La Sabana, Chía 250001, Colombia.ORCID 0009-0007-1196-7056
Jacobo Echeverri-HoyosSchool of Medicine, Institución Universitaria Visión de las Américas, Pereira 660000, Colombia.
Jaime A Echeverri-FrancoPulmonology, Clínica de Alta Tecnología Oncólogos del Occidente, Pereira 660000, Colombia.
Eduardo Tuta-QuinteroDepartment of Epidemiology and Internal Medicine, School of Medicine, Universidad de La Sabana, Chía 250001, Colombia.ORCID 0000-0002-7243-2238

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEsophageal cancer is a highly lethal malignancy, the prognosis of which depends largely on early diagnosis. Artificial intelligence (AI) has emerged as a promising tool to enhance endoscopic detection and characterization of early esophageal cancer. This scoping review aims to map and synthesize the available evidence regarding the diagnostic performance and clinical utility of artificial intelligence systems applied to upper gastrointestinal endoscopy for the detection and characterization of premalignant squamous lesions and early-stage esophageal squamous cell carcinoma (ESCC).

methodsA scoping review was conducted according to Arksey and O'Malley, Levac, Joanna Briggs Institute, and PRISMA-ScR recommendations. The review question focused on patients with premalignant lesions or early ESCC, artificial intelligence-based diagnostic systems, and upper gastrointestinal endoscopy. Searches were performed in PubMed, Scopus, and Embase. Original studies reporting sensitivity, specificity, accuracy, AUC, or F1-score were included.

resultsA total of 30 publications were included, consisting mainly of retrospective observational and diagnostic test studies (26/30; 86.7%), followed by randomized clinical trials (3/30; 10.0%) and a multicenter validation study (1/30; 3.3%). The studies were predominantly from China (18/30; 60%), followed by Japan (8/30; 26.7%), Taiwan (3/30; 10%), and the United Kingdom + Taiwan (1/30; 3%). Automatic lesion detection was predominant (21/30; 70.0%), followed by diagnostic classification (11/30; 36.7%), while segmentation (3/30; 10.0%), histological prediction (2/30; 6.7%), estimation of invasion depth (3/30; 10.0%), and lesion delineation (1/30; 3.3%) were evaluated less frequently, and in some cases combined within the same model. The most used endoscopic imaging modalities were narrow-band imaging (23/30; 76.7%) and white light endoscopy (20/30; 66.7%), followed by magnifying endoscopy with narrow-band imaging (5/30; 16.7%), blue light imaging (2/30; 6.7%), and hyperspectral imaging (1/30; 3.3%).

conclusionsAvailable studies suggest that AI has the potential to achieve high diagnostic performance under controlled conditions. However, the current evidence is derived predominantly from single-center retrospective studies using selected high-quality static images, with limited external, prospective, and real-world validation.

Indexed as

artificial intelligencecancerdiagnosticesophageal cancerscoping review

Identifiers

PMID42512301
PMCPMC13406400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.